drugset / Trial / NCT06290375
A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a two- stage study. Stage I is a multicenter, open-label trial；Stage II was a multi-center, randomized, double-blind, placebo-controlled trial. About 250 maintenance peritoneal dialysis patients with moderate or above pruritus are planned to be enrolled.
Timeline
- Start
- 2024-03-08
- Primary completion
- 2024-03-08
- Completion
- 2025-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK21542 | Peptide | 2 mg | — |
Indications
No indication recorded.